上海博研生物工程研究中心為您現貨提供*的產品與服務，本中心產品齊全，保證實驗的有效性，提供，是您科研實驗產品的一站式平臺，咨詢。！

產品名稱：Anti-HPV18 E6 protein抗體,人類乳頭狀瘤病毒18 E6抗體勁爆優惠
中文名稱：人類乳頭狀瘤病毒18 E6抗體
英文名稱：Anti-HPV18 E6 protein
產品編號：BYK-0991R
產品別名：E6; Human Papilloma Virus; Human papillomavirus type 18 E6; Human papillomavirus type 18 （E6）; Human papillomavirus type 18 E6; Human papillomavirus type 18 E6 protein; Protein E6; HPV18 E6 protein; VE6_HPV18.

本公司另供應“人類乳頭狀瘤病毒18 E6抗體”的標記有：Alexa Fluor 350 Alexa Fluor 488 Alexa Fluor 555 Alexa Fluor 647 AP APC Biotin Cy3 Cy5 Cy5.5 Cy7 FITC Gold HRP PE PE-Cy3 PE-CY5 PE-CY5.5 PE-CY7 RBITC.
產品規格：100ug/200ug
產品濃度： 1mg/1ml
抗體來源：兔源、鼠源、山羊
克 隆：單克隆抗體、多克隆抗體
抗體類型：一抗
性 狀： 凍干粉或液體
保存條件：Store at -20 °C for one year. Avoid repeated freeze/thaw cycles. The lyophilized antibody is stable at room temperature for at least one month and for greater than a year when kept at -20°C. When reconstituted in sterile pH 7.4 0.01M PBS or diluent of antibody the antibody is stable for at least two weeks at 2-4 °C.

Anti-HPV18 E6 protein抗體,人類乳頭狀瘤病毒18 E6抗體勁爆優惠技術說明，產品*，由于篇幅原因，更多信息請：

Anti-Phospho-HP1（pTyr43）（Phospho-heterochromatin protein 1）（fruit fly）  抗異染色質蛋白1磷酸化抗體（果蠅）
Anti-HPV （Human papillomavirus）  人類乳頭狀瘤病毒抗體
Anti-HPV16-E6/E6 protein（Human papillomavirus type 16）  人類乳頭狀瘤病毒16抗體
Anti-HPV18-E6/E6 protein（Human papillomavirus type 18）  人類乳頭狀瘤病毒18抗體
Anti-HPV16-E7/E7 protein（Human papillomavirus type 16）  人類乳頭狀瘤病毒16-E7抗體
Anti-HLA-DR （human leukoyte Antigen DR）  HLA-DR抗原抗體
Anti-HLA-G （Human Leukocyte Anti-gen-G）  人類白細胞抗原G/組織相容性白細胞抗原G抗體
Anti-HMGB4（High Mobility Group Box protein 4）  高遷移率族蛋白B4抗體
Anti-HNF-1α（Hepatocyte nuclear factor 1α）  肝細胞核因子1α抗體
Anti-HO-1/HSP32 （Hemeo xygenase 1）  血紅素氧合酶-1/熱休克蛋白-32抗體
Anti-HO-2 （Heme oxygenase 2）  血紅素氧合酶-2抗體
Anti-HOXc8  同源盒基因的一種
Anti-HPA（heparanase）  抗乙酰肝素酶抗體
Anti-phospho-HP1（pTyr）（phospho-heterochromatin protein 1）（fruit fly）  抗異染色質蛋白1磷酸化抗體（果蠅）
Anti-HOXA10 （homeobox protein A10）  HOXA10抗體

產品介紹：

Human papilloma viruses （HPVs） can be classified as either high risk or low risk according to their association with cancer. HPV16 and HPV18 are the most common of the high risk group while HPV6 and HPV11 are among the low risk types. Approximay 90% of cervical cancers contain HPV DNA of the high risk types. Mutational analysis have shown that the E6 and E7 genes of the high risk HPVs are necessary and sufficient for HPV transforming function. The specific interactions of the E6 and E7 proteins with p53 and pRB, respectively, correlate with HPV high and low risk classifications. The high risk HPV E7 proteins bind to pRB with a higher affinity than do the low risk HPV proteins, and only the high risk HPV E6 proteins form detectable complexes with p53 in vitro.